Abnormal Development - Folic Acid and Neural Tube Defects

From Embryology
Revision as of 18:11, 11 August 2010 by S8600021 (talk | contribs) (Created page with ' == Abnormal Development - Folic Acid and Neural Tube Defects == == Introduction == In 2001, the Australian estimated birth prevalence of neural tube defects was 0.5 per 1,000 b…')
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Abnormal Development - Folic Acid and Neural Tube Defects

Introduction

In 2001, the Australian estimated birth prevalence of neural tube defects was 0.5 per 1,000 births (National Perinatal Statistics Unit).


File:Folate.gif
Folatefruit.jpg
Folic Acid
Fruits

Research over the last 20 years has suggested a relationship between maternal diet and the birth of an affected infant, and recent evidence has confirmed that folic acid, a water soluble vitamin, found in many fruits (particularly oranges, berries and bananas), leafy green vegetables, cereals and legumes, may prevent the majority of neural tube defects.

In the U.S.A. the Food and Drug Administration in 1996 authorized that all enriched cereal grain products be fortified with folic acid, with optional fortification beginning in March 1996 and mandatory fortification in January 1998. (More? [#USAdata USA Data])

The March of Dimes Folic Acid Campaign (a major US charity group) has as one of its major objectives to reduce neural tube defects by 30% by 2001 using community programs, professional education, and mass media information.

Page Links: [#Intro Introduction] | [#Recent Recent Articles] | [#AustralianStatistics Australian Statistics] | [#USAdata USA Statistics] | [#Folic Acid Folic Acid] | [#WWWLinks WWW Links] | [#References References] | [#Glossary Glossary]

See also: [spinabifida.htm Spina Bifida] | [../Notes/neuron2.htm Neural Abnormalities notes]

Some Recent Findings

Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006 Apr 22;367(9519):1352-61. "... In the USA, Canada, and Chile, mandatory fortification of flour substantially improved folate and homocysteine status, and neural tube defects rates fell by between 31% and 78%. Nevertheless, many countries do not choose mandatory folic acid fortification, in part because expected additional health benefits are not yet scientifically proven in clinical trials, in part because of feared health risks, and because of the issue of freedom of choice. Thus, additional creative public-health approaches need to be developed to prevent neural tube defects and improve the folate status of the general population."

Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto). 2006 Jun;46(2):55-67.

Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006 May;83(5):993-1016.

Wen SW, Walker M. An exploration of health effects of folic acid in pregnancy beyond reducing neural tube defects. J Obstet Gynaecol Can. 2005 Jan;27(1):13-9.

Gonzalez MJ, et al. [See Related Articles] Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci J. 1997 Dec;16(4):387-93. Review.

Australian Statistics

  • Women who have one infant with a neural tube defect have a significantly increased risk of recurrence
    • 40-50 per thousand compared with 2 per thousand for all births.
  • A randomised controlled trial conducted by the Medical Research Council of the United Kingdom demonstrated a 72% reduction in risk of recurrence by periconceptional (ie before and after conception) folic acid supplementation (4mg daily).
  • Other epidemiological research, including work done in Australia, suggests that primary occurrences of neural tube defects may also be prevented by folic acid either as a supplement or in the diet.
  • This has been confirmed in a randomised controlled trial from Hungary, which found that a multivitamin supplement containing 0.8mg folic acid was effective in reducing the occurrence of neural tube defects in first births.
(Data excerpt from NHMRC Publication)

USA Statistics

In the U.S.A. the Food and Drug Administration in 1996 authorized that all enriched cereal grain products be fortified with folic acid, with optional fortification beginning in March 1996 and mandatory fortification in January 1998. The data below shows the subsequent changes in anencephaly and spina bifida rate over that period.

File:USAspinabifida2.jpg

File:USAanencephaly2.jpg

Data: CDC Trends in Spina Bifida and Anencephalus in the United States, 1991-2005

Folic Acid

Formula: C19H19N7O6

Alternate Names: Folic acid, Folate, Pteroylglutamic acid


File:Folatesynth.gif

(Data from KEGG)

Folate Biosynthesis(click image for full size or get original Map)

WWW Links

Australian NHMRC

The Australian NHMRC (1988) recommends neonates be assessed for follow-up care under the following conditions.

(see the NHMRC WWW Page)
  • Birthweight less than 1500g or gestational age less than 32 weeks
  • Small-for-gestational-age neonates
  • Perinatal asphyxia
  • Apgar score less than 3 at 5 minutes
  • clinical evidence of neurological dysfunction
  • delay in onset of spontaneous respiration for more than 5 minutes and requiring mechanical ventilation
  • Clinical evidence of central nervous system abnormalities ie., seizures, hypotonia
  • Hyperbilirubinaemia of greater than 350umol/l in full term neonates
  • Genetic, dysmorphic or metabolic disorders or a family history of serious genetic disorder
  • Perinatal or serious neonatal infection including children of mothers who are HIV positive
  • Psychosocial problems eg., infants of drug-addicted or alcoholic mothers.

For Normal Childhood Development [../Child/page4.htm see Publications] (or NHMRC WWW Page)

References

Reviews

Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006 Apr 22;367(9519):1352-61.

Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto). 2006 Jun;46(2):55-67.

Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006 May;83(5):993-1016.

Wen SW, Walker M. An exploration of health effects of folic acid in pregnancy beyond reducing neural tube defects. J Obstet Gynaecol Can. 2005 Jan;27(1):13-9.

Gonzalez MJ, et al. [See Related Articles] Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci J. 1997 Dec;16(4):387-93. Review.

Articles

I have included an earlier (1999) search [../Refer/abnorm/folica_rev.htm list of selected review articles] from PubMed Medline 1969-99. Also [../Refer/abnorm/folica_select.htm selected a few abstracts] from reviews.